Capital Investment Advisory Services’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Capital Investment Advisory Services’s Portfolio FTXH Stock Details FTXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.2K	Hold	450	–	–	﹤0.01%	1102
2026 Q1	$15.5K	Hold	450	–	–	﹤0.01%	1017
2025 Q4	$14.8K	Hold	450	–	–	﹤0.01%	981
2025 Q3	$12.8K	Hold	450	–	–	﹤0.01%	942
2025 Q2	$11.5K	Hold	450	–	–	﹤0.01%	929
2025 Q1	$12.4K	Hold	450	–	–	﹤0.01%	859
2024 Q4	$12.1K	Hold	450	–	–	﹤0.01%	797
2024 Q3	$13K	Hold	450	–	–	﹤0.01%	835
2024 Q2	$12.3K	Hold	450	–	–	﹤0.01%	814
2024 Q1	$12.6K	Hold	450	–	–	﹤0.01%	806
2023 Q4	$12K	Buy	+450	New	+$11.3K	﹤0.01%	819

Other funds holding FTXH

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

MIM

Marshall Investment Management Littleton, Colorado $241M AUM 30.53% 1-Year Est. Return

Ameritas Investment Partners Lincoln, Nebraska $3.75B AUM 46.53% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Nilsine Partners Greenwood Village, Colorado $1.45B AUM 47.06% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Capital Investment Advisory Services's FTXH Position: Q2 2026 in Review

Capital Investment Advisory Services held its First Trust Nasdaq Pharmaceuticals ETF (FTXH) position steady in Q2 2026 at 450 shares worth $17.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1102.

Capital Investment Advisory Services first reported a position in FTXH in Q4 2023 and has held it in 11 quarters since. 30 funds tracked by Wall St. Rank hold FTXH as of Q2 2026.

Capital Investment Advisory Services held 450 shares of First Trust Nasdaq Pharmaceuticals ETF worth $17.2K as of Q2 2026.
Capital Investment Advisory Services left its First Trust Nasdaq Pharmaceuticals ETF share count unchanged in Q2 2026.
First Trust Nasdaq Pharmaceuticals ETF made up ﹤0.01% of Capital Investment Advisory Services's portfolio in Q2 2026, its #1102 holding.
Capital Investment Advisory Services first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q4 2023 and has held it in 11 quarters since.
30 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q2 2026.

Based on Capital Investment Advisory Services's 13F filing for Q2 2026, filed 23 Jul 2026.